Adults with AIP report broad use of cannabis and alternative care
Survey of 82 adults found use was common, but benefits remain uncertain
Written by |
Many adults with acute intermittent porphyria (AIP) reported using cannabis and complementary and alternative care, including chiropractic and acupuncture, for symptoms or general well-being, a study found. However, more research is needed to determine whether these approaches are safe and effective.
The U.S.-based study, “Complementary and alternative medicines and cannabis use among individuals with acute intermittent porphyria,” was published in Molecular Genetics and Metabolism.
Study explores alternative care use in adults with AIP
Porphyria comprises a group of genetic disorders in which the body cannot properly produce heme, a part of hemoglobin, the protein that carries oxygen in red blood cells. People with porphyria can experience sudden attacks of symptoms, including intense abdominal pain and nervous system problems, called neurovisceral attacks.
Although treatments are available, long-lasting symptoms can persist and reduce quality of life. The study examined how adults with diagnosed or self-reported AIP used cannabis and complementary and alternative medicine, which includes products and practices outside standard medical care, for symptom management and general well-being.
The study recruited 82 participants from the Longitudinal Study of the Porphyrias Consortium (NCT01561157) and a patient advocacy group. Participants responded to an anonymous online survey about which treatments they used and how well they thought those treatments worked. Most participants (87.8%) were women, and the average age was 43.9 years.
Nearly all participants (92.7%) had experienced at least one acute attack of AIP, with attacks beginning at an average age of 24.4 years. Among those who had experienced acute attacks, 78.9% were still experiencing them when the survey was completed. Among that same group, nearly two-thirds (63.2%) reported recurrent attacks, defined as four or more per year.
Persistent symptoms were common, with over two-thirds of participants (68.3%) reporting a history of chronic symptoms beginning at an average age of 30.2 years. The most common symptoms were fatigue (71.4%), muscle weakness (60.7%), other pain (58.9%), and nausea (55.4%). Most participants who reported chronic symptoms were still experiencing them when surveyed.
More than two-thirds of participants (68.3%) reported having tried cannabis in some form. Many used it to manage AIP symptoms, while others reported using it for both symptom relief and recreational purposes. Most reported using products containing tetrahydrocannabinol (THC), the main intoxicating compound in cannabis, although some reported using only cannabidiol (CBD), a non-intoxicating cannabis compound.
Cannabis experiences and symptom burden varied
Participants who had used cannabis generally reported a higher symptom burden. Compared with those who had not used cannabis, a larger proportion were still experiencing acute attacks and had experienced chronic symptoms. A questionnaire indicated low overall cannabis use, and because this was a survey, it is unclear whether cannabis actually eased symptoms.
During the previous year, some participants (17.1%) had visited a chiropractor, who treats problems involving muscles and joints using manual techniques, and about as many (14.6%) had visited an acupuncturist, who inserts very thin needles into specific points on the body. Most of those who visited chiropractors or acupuncturists rated them as very helpful. Other participants visited massage therapists, spiritual healers, homeopaths, and herbalists.
Most participants (90.2%) had also seen a doctor during the previous year. Of those participants, 43.2% said long-term AIP symptoms were the reason for their most recent visit. Some doctors provided complementary and alternative treatments such as acupuncture, homeopathy, spiritual healing, or hypnosis. Most of these treatments were rated as somewhat or very helpful.
More than half of participants (56.1%) used herbs or dietary supplements. The most common products were multivitamins, vitamin D, vitamin B12, and magnesium. Self-help practices were also common, with more than half of participants using relaxation techniques (57.3%) or meditation (53.7%), mainly to help control persistent symptoms or improve their general well-being.
Overall, “these findings highlight unmet needs in AIP management and emphasize the importance of further research to evaluate the safety, effectiveness, and integration of [complementary and alternative medicine] into patient-centered care strategies,” the researchers concluded.
Judith Sparagna
I have taken gummies with thc and find it not only dramatically improves my general outlook, but actually halts my AIP symptoms
Aletta
I am the founder of the Verigate Porphyria Patient support group in South Africa, namely: SOUTH AFRICAN PORPHYRIA FOUNDATION, AKA: SAPF) , and I'm very interested to continue this conversation with Dr. Magarinda and all involved in the treatment reasurch within THC & CBD realm.
Would you be so kind to add me to all related THC- & CBD resurch and conversations related to PORPHYRIA treatment please?
We have been looking into THC & CBD since 2020, and is still doing so quietly.
Variegate Porphyria is very prominent in South Africa, as you know, as it is the origin/birthplace of this horrific strain of PORPHYRIA, and symptomatic patients are constantly looking for effective treatment.
PORPHYRIA is not only restricted to white Afrikaans South Africans any more, but spans across all bloodlines. Although the Afrikaans community is still the majority of patients coming forward. Due to old and conservative perceptions among this community, a product such as THC is still frowned upon by the elders.
This, and the stigma attached to this drug must be changed.
We strive to not only create awareness of the disease itself, but also all treatments availible.
I personally believe THC has incredible potential to help patients long term , and with the finest product and new resurch and education this product will make life more manageable for many VP'ers.
I also believe we can contribute greatly not only as VP patiens & patriots, but also as supporters of THC as an effective developing treatment for Porphyria and many other diseases.
We are looking forward to hear from you and become actively involved in the reasurch, conversation and facilitating where we can, around THC- & CBD-development for PORPHYRIA.
THANK YOU for all the work this far.
Kind regards,
Aletta Longari
Founder of SOUTH AFRICAN PORPHYRIA FOUNDATION🇿🇦
WhatsApp: +27835842263
Cape Town, RSA.